MentionFox
Home › funding signals › Upstream Metabolics, Inc.
Form D · on the record

Upstream Metabolics — $50K Form D filing, September 2026

Upstream Metabolics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-09-29.

Upstream Metabolics, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 29, 2026. The filing reports $50K sold. Its industry group is Other Health Care. It names Sam Thorpe (Executive Officer, Director), Ashley Smith (Executive Officer, Director) (SEC Form D, September 29, 2026).

5 more Other Health Care raises in California, September 2026 ↓

Sell to companies like Upstream Metabolics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Key facts

Run the free check on Upstream Metabolics, Inc. →

Upstream Metabolics, Inc.

New Form D on file · 2026-09-29 · the record

$50K
raise on the record
D
filing
1
investors in
CALIFORNIA
based
Open the record →

What the record says

FilingForm D
Filed2026-09-29
Industry groupOther Health Care
Entity typeCorporation
Incorporated inDELAWARE
Year formed2026
BasedLAFAYETTE, CALIFORNIA
CIK2151718
Accession0002151718-26-000001

Pitching, partnering or investing alongside them? See who really runs and owns Upstream Metabolics, Inc.

Watch Upstream Metabolics, Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Upstream Metabolics, Inc., from the filings we hold.

More raises like this

Other Health Care raises by companies based in California, filed in September 2026, largest first.

What do you want to do with Upstream Metabolics, Inc.?

Get the full cited report on Upstream Metabolics, Inc.

What the filing shows about Upstream Metabolics, Inc.

  • The filing reports $10K of the proceeds going to the company's own executives, directors or promoters.
  • 1 investor had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Upstream Metabolics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

What the filing says

  • Offered: $150,000. Sold: $50,000. Left to sell: $100,000. (filing)
  • Investors: 1 had already invested. (filing)
  • Date of first sale: September 21, 2026. (filing)
  • Types of securities: Other: Simple Agreement for Future Equity (SAFE). (filing)
  • Item 16, payments to executive officers, directors or promoters: $10,000 of the proceeds is used or proposed to be used for such payments (the filing marks this amount as an estimate). The filing gives no explanation. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Upstream Metabolics, Inc. See pricing

Other Health Care · by week
This raise, $50K, filed week of Sep 28

Trailing twelve months. 866 filings in Other Health Care, totalled by week. The dot is this raise, $50K, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Upstream Metabolics, Inc.?

What the filing shows about Upstream Metabolics, Inc.

  • The filing reports $10K of the proceeds going to the company's own executives, directors or promoters.
  • 1 investor had already put money in when it filed.
  • The filing names 2 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Upstream Metabolics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Upstream Metabolics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Upstream Metabolics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for Upstream Metabolics, Inc.. With no account yet, you sign up free and land on the result.

On these lists: San Francisco Bay Area raises, week of 2026-09-28 · Health care raises, week of 2026-09-28 · Health care raises in San Francisco Bay Area

Share this page

Just raised? Share it.

Upstream Metabolics, Inc.: Raised $50K, Form D filed 2026-09-29
Download image Share on LinkedIn Share on X

Cite this page

Permanent URL: https://mentionfox.com/funding/upstream-metabolics-inc-form-d-000001
Last updated 2026-10-20
Primary record: SEC filing 1 · SEC filing 2
Upstream Metabolics raised $50K — SEC Form D filing, September 2026. MentionFox, 2026-10-20. https://mentionfox.com/funding/upstream-metabolics-inc-form-d-000001